Center of Excellence for Cannabis Care opens in Albany – NEWS10 ABC

#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians now have access to a specialized resource for evidence-based cannabis guidance at a time when patient use is increasing and many providers lack formal training in this area. The center can help bridge gaps in clinical knowledge about cannabis pharmacology, drug interactions, dosing, and adverse effects, enabling better-informed conversations with patients who are using or considering cannabis. This institutional support is particularly important given that cannabis remains understudied relative to its prevalence, and clinicians need reliable evidence to assess therapeutic benefit against potential harms for their individual patients.
A Center of Excellence for Cannabis Care has opened in Albany to provide clinical education and support infrastructure as cannabis use becomes increasingly prevalent in New York healthcare settings. This center aims to establish evidence-based protocols and standardized approaches for cannabis counseling, product selection, and patient monitoring across healthcare systems and clinician practices. By centralizing expertise and resources, the center addresses the knowledge gap many clinicians face when patients present with cannabis-related questions or seek medical cannabis recommendations. The initiative reflects the growing recognition that as cannabis legalization expands, clinicians need institutional support to safely integrate cannabis into comprehensive patient care while managing potential drug interactions, contraindications, and adverse effects. For busy practices, access to a regional center of excellence can reduce the burden of staying current on cannabis pharmacology, dosing, and evidence while improving consistency across different clinical settings. Clinicians should consider leveraging such regional resources to enhance their cannabis counseling competency and provide evidence-informed guidance to patients considering or already using cannabis products.
“What we’re seeing with centers like this is an important step toward standardizing how we approach cannabis in clinical practice, but we need to be clear that opening a facility doesn’t automatically resolve our evidence gaps. We still lack large, well-designed human trials on many conditions where patients are using cannabis, so my role as a clinician remains one of careful assessment, honest discussion about what we know versus what we’re still learning, and thoughtful integration with conventional care.”
💊 The opening of a Center of Excellence for Cannabis Care in Albany reflects the growing need for evidence-based clinical guidance as cannabis use becomes increasingly prevalent among patients across New York. While this development may help standardize education and best practices for healthcare providers managing cannabis-using populations, clinicians should recognize that cannabis research remains limited compared to other therapeutic areas, with significant gaps in long-term safety data, optimal dosing, and drug interaction profiles. The quality and accessibility of resources from such centers will vary, and providers must still critically appraise recommendations against individual patient contexts, including psychiatric comorbidities, pregnancy status, and potential cannabis use disorder. As cannabis legalization continues, having centralized clinical expertise available can help reduce knowledge gaps and improve screening and counseling conversations, ultimately supporting more informed shared decision-making with patients who use or are considering cannabis.
This topic comes up in consultations often.
Dr. Caplan offers clinical context on evolving cannabis policy and its real-world implications for patients.
Book a consultation →💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
